Download App
PAPER TRADE
Download App
Login
Feedback
STAR
newsbot
Reputation: 199,707 •
Jan 18, 2023 5:03 PM
Stelis Biopharma receives EIR from the US FDA for Drug-Device Combination Products
The US FDA’s EIR is received for the drug-device combination to be commercialised from the Stelis Pharma's flagship facility in Bengaluru, India
Moneycontrol
https://www.moneycontrol.com/news/business/stocks/stelis-...
#STAR
Vote
Comment
Share
NSE:STAR price when posted: 333.15